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Abstract 
Podocalyxin (Podxl) has an essential role in the development and function of the kidney glomerular 
filtration barrier. It is also expressed by vascular endothelia but perinatal lethality of podxl-/- mice has 
precluded understanding of its function in adult vascular endothelial cells (ECs). In this work, we 
show that conditional knockout mice with deletion of Podxl restricted to the vascular endothelium 
grow normally but most die spontaneously around three months of age. Histological analysis showed a 
nonspecific inflammatory infiltrate within the vessel wall frequently associated with degenerative 
changes, and involving vessels of different caliber in one or more organs. Podxl-deficient lung EC 
cultures exhibit increased permeability to dextran and macrophage transmigration. After thrombin 
stimulation, ECs lacking Podxl showed delayed recovery of VE-cadherin cell contacts, persistence of 
F-actin stress fibers, and sustained phosphorylation of the ERM complex and activation of RhoA, 
suggesting a failure in endothelial barrier stabilization. The results suggest that Podxl has an essential 
role in the regulation of endothelial permeability by influencing the mechanisms involved in the 
restoration of endothelial barrier integrity after injury. 
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Introduction 
Podocalyxin (Podxl) is an extensively O-glycosylated and sialylated type I transmembrane protein, 
closely related to CD34 and endoglycan. It was originally described in kidney podocytes (Kerjaschki 
et al., 1984) playing an essential role in the development and function of the kidney glomerular 
filtration barrier (Doyonnas et al., 2001). Podxl is also normally expressed on vascular endothelial 
cells (ECs) (Horvat et al., 1986), megakaryocytes and platelets (Kerosuo et al., 2004; Miettinen et al., 
1999) and in some subsets of neurons (Vitureira et al., 2005).  Aberrant expression of Podxl has been 
demonstrated in a number of cancers (Casey et al., 2006; Schopperle et al., 2003; Somasiri et al., 
2004). Recent reports have provided useful data on the role of extrarenal Podxl. Platelet Podxl is 
involved in the control of haemostasis (Alonso-Martín et al., 2010; Pericacho et al., 2011). In brain, it 
seems to play multiple roles in neural development (Nowakowski et al., 2010; Vitureira et al., 2010). 
Podxl is not essential for hematopoiesis, but it may facilitate the crossing of endothelial barriers 
during migration to distant hematopoietic microenvironments (Doyonnas et al., 2005). Finally, 
overexpression of Podxl in cancer cells is associated with poor prognosis and metastasis (Boman et 
al., 2013; Dallas et al., 2012). 
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One of the most intriguing questions of Podxl research that remains unclear is whether the 
presence of this protein in ECs has pathophysiological relevance. Podxl is a widespread component of 
ECs in blood vessels of all calibers in a number of organs (lung, heart, small intestine, pancreas, 
kidney), but it is absent in the sinusoidal capillaries of liver and spleen (Horvat et al., 1986; Miettinen 
et al., 1990). In the specialized postcapillary high endothelial venules (HEV), Podxl was identified as 
one of the ligands for L-selectin (Sassetti et al., 1998). The apparently normal development of 
vascular ECs in Podxl-deficient mice was attributed to functional compensation by other sialomucins, 
such as CD34 (Doyonnas et al., 2001). Later, it was suggested that localization of Podxl at the 
endothelial cell-cell contacts is important to define the luminal cell surface during aorta development 
(Strilic et al., 2009). However, perinatal lethality of podxl-/- mice has precluded full understanding of 
its biological functions in adult vascular ECs. 
We have recently generated a Podxl “floxed” mouse line in which podxl alleles carry loxP sites 
flanking a DNA fragment comprising exons 5-7 (Nowakowski et al., 2010; Pericacho et al., 2011). In 
the present work, to determine whether Podxl plays a role in regulating EC functions, these mice were 
crossed with the Tie2-Cre mouse line that produces Cre recombinase in endothelial and some 
hematopoietic cells (Kisanuki et al., 2001). We show evidence indicating that Podxl expression in ECs 
is essential for the maintenance of endothelial barrier integrity in vivo as well as in vitro. Podxl-
deficient mice develop severe vasculitis leading to organ failure and premature death. In addition, 
permeability and macrophage transmigration were significantly increased in Podxl-deficient 
monolayers of lung ECs. The results suggest that Podxl is required to reestablish vascular integrity by 
ensuring proper cell-cell junctions. 
 
 
 
 
Methods 
Animals 
Mice (Mus musculus) used in all the experiments were maintained under controlled conditions of 
light and temperature. Podxlf/f::Tie2-Cre littermates were generated on a mixed CD1;129-P genetic 
background. To generate mice with a restricted deletion of Podxl in endothelial cells, mice 
homozygous for the floxed allele (with exons 5-7 flanked by functional loxP sites) generated 
previously (Nowakowski et al., 2010) were backcrossed for 10 generations with CD1 mice and 
crossed to Tie2-Cre mice (kindly gifted by Dr. J. L. de la Pompa, National Centre of Biotechnology, 
Madrid, Spain) (Kisanuki et al., 2001). 
All experiments with animals were done in such a way as to minimize animal suffering, according 
to relevant national and international guidelines. Animals were killed by cervical dislocation under 
anesthesia by 3% isoflurane inhalation. The ethics committee of the Center for Biological Research 
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(CSIC) and the grant review board (ANEP) of the Spanish Ministry of Science and Technology 
specifically approved this study in accordance with the Directive 2010/63/EU of the European 
Parliament. 
Some “floxed” (control mice) and Podxl-deficient mice (KO mice) were treated with 
intraperitoneal injection of phenol-purified lipopolysaccharides (LPS) from E. coli (Sigma), at a dose 
of 10-40 mg/Kg in a volumen of 100 µL PBS. Control animals were injected with the same volume of 
PBS. 
 
PCR genotyping 
For littermate genotyping, tail genomic DNA and oligonucleotides S-exon7: 5’-
CTTGTTGCTGCCCTCTACGGCTGC-3’ and AS-intron7: 5’-
CCACATTTGAGTCTCCAGCGTTAG-3’ were used to verify amplification of a 253 bp-DNA 
fragment comprising the right loxP sequence, and identification of Cre+ mice was performed by 
amplification of a DNA fragment with a sense oligonucleotide (5’-
GGGAAGTCGCAAAGTTGTGAGTT-3’) targeting a sequence of the Tie2 promoter and an antisense 
primer (5’-CTAGAGCCTGTTTTGCACGTCC-3’) targeting the Cre gene sequence. 
 
RT-PCR analysis of Podxl expression 
Total RNA from mouse lung endothelial cells (MLECs) and platelets was obtained using the “High 
Pure RNA Isolation Kit” from Roche. RT-PCR amplification with oligonucleotides S-exon4: 5’-
GTGAACCTCCCATAAGGCCAG-3’ located in exon 4 and AS-exon8: 5’-
TGTCCAGAGGGACGATCCAA-3’ located in exon 8 confirmed normal sized cDNA in MLECs and 
platelets from “floxed” mice (control mice) and the deletion of exons 5-7 in cells from Cre+ mice (KO 
mice). Relative quantification of the normal Podxl mRNA transcript was assessed by real time RT-
PCR using oligonucleotides S-exon7: 5’-CCTTCCTGCTCCTTGTTGCTG-3’ and AS-exon8. In all 
RT-PCR assays, amplification of a cDNA fragment of mouse β-actin was carried out in parallel to 
verify that equal amounts of RNA were used ensuring correct normalization of Podxl expression. 
 
Serum and urine biochemistry 
Serum was obtained from non-citrated-blood samples. Blood was collected through cardiac 
puncture and stored overnight at 4ºC to permit complete blood coagulation. Serum was separated by 
centrifugation at 1500 g for 5 minutes. Serum and urine samples from 3-month old mice were 
biochemically analyzed to study cardiac and renal parameters (Hitachi 917, RCV Laboratories). Urine 
volume was determined using metabolic cages in two matched groups of six control and six Podxl-
deficient mice with an equal number of males and females. Urinary protein and glucose excretion 
were measured in two 48-hour urine samples. 
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Tail-cuff measurement of blood pressure 
Systolic and diastolic blood pressure was measured in 3-month old mice using the non-invasive 
computerized tail-cuff system BP-2000 (Visitech Systems, Cary, NC). Conscious mice were trained 
for 4 days before starting the measurement to prevent stress. Arterial pressure as well as heart rate was 
measured during 10 consecutive days, with at least 20 determinations per day. 
 
Magnetic resonance image 
The lumen of the abdominal aorta was analyzed by magnetic resonance imaging (MRI) in three 
control and three KO mice of 3 months of age, using a 7 Tesla Bruker Pharmascan (Bruker Medical 
Gmbh, Ettlingen, Germany). Fourteen axial slices between the diaphragm muscle and the common 
iliac arteries were acquired and the area corresponding to the vascular lumen in each section was 
analyzed using the ImageJ software. 
 
Thrombogenesis in vivo 
As previously reported (Pericacho et al., 2011), 100 µL of blood was collected from one of the 
jugular veins of anesthetized mice into a tube containing 10 µL of 0.129 mol/L sodium citrate. A 
mixture of collagen/epinephrine (150 ng collagen type I (Chronolog) and 15 ng epinephrine (SIGMA) 
per g of mice body weight) was then injected into the same vein and, after 2 minutes, blood was 
withdrawn from the other jugular vein as indicated above. The number of platelets in both samples 
was determined using a hemocytometer analyzer Abacus Junior (Diatron Messtechnik GmbH, 
Austria). 
 
Histological analysis 
Tissue samples were collected immediately after euthanization and were fixed overnight in 4% 
paraformaldehyde, dehydrated, and paraffin-embedded. Serial 3-µm histological sections were 
prepared according to standard protocols and stained with hematoxylin/eosin for light microscopy. 
Histological analysis was performed blinded to the genotype by pathologists of Department of 
Pathology at the University of Santiago de Compostela. The following features were considered to 
define histopathological lesions: (1) Vasculitis/arteritis: the main histopathologic feature to define 
arteritis was the presence of an inflammatory infiltrate within the vessel wall. Disruption of the 
endothelial lining and the presence of edema together with inflamatory cells were also found. (2) 
Myocardial degeneration: disorganization of architecture of myocardial fibers, overgrowth of 
interstitial fibrous tissue, and necrosis areas. (3) Bronchopneumonia nonsuppurative: alveolar edema 
and accumulation of inflammatory cells in the alveolar wall and surrounding pulmonary vessels. (4) 
Mild glomerulonephritis: mild but significant increase of cellularity in renal glomeruli (proliferative 
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glomerulitis). (5) Hepatic micronecrosis: Unstructured small eosinophilic areas devoid of nuclei and 
surrounded by inflammatory cells. 
Immunofluorescence detection of Podxl and PECAM-1 in kidney sections was carried out by 
sequential staining with goat polyclonal anti-Podxl (AF1556, R&D) and anti-PECAM-1 (sc-1506, 
Santa Cruz Biotechnology) antibodies.  
 
Mouse lung endothelial cell isolation and culture 
To prepare mouse lung endothelial cell (MLEC) cultures from 2-3 control or KO aged 3-months 
we introduced some modifications to previously described protocols (Fehrenbach et al., 2009). 
Briefly, animals were anesthetized with isofluorane, euthanized by dislocation, and dissected. First 5 
mL of cold medium were injected into the right ventricle to flush the lung of blood cells and, then, 2 
mL of 1.5 mg/mL collagenase A (Roche) was rapidly instilled through the trachea into the lungs. The 
lungs were removed and incubated with 6 ml of collagenase A in a 50-ml tube for 30 minutes in a 
37°C water bath and gentle agitation every 10 minutes. After adding 25 ml of PBS, the tube was then 
shaken vigorously for 30 seconds and the resulting tissue/cell suspension was sieved through a 70-µm 
cell strainer and centrifuged for 5 minutes at 1000 rpm. The cell pellet was washed once with 
complete DMEM and, then, resuspended in 5 mL of the same medium and plated into a gelatin-coated 
100 mm-plate. Resuspended cells from one or two more animals were seeded in the same plate. After 
24 hours, the medium was changed to 50% DMEM-50% Hams F-12 medium supplemented with 
penicillin/streptomycin, 20% fetal bovine serum, 20 µg/mL endothelial cell growth supplement from 
bovine neural tissue (ECGS, Sigma) and 0.1 mg/mL heparin sodium salt (Sigma), and the cells 
cultured for 2 days. Cells were then removed by trypsin and purified by a single positive sorting using 
anti-ICAM-2 antibody (553326, BD Pharmigen) previously coupled to sheep anti-rat IgG Dynabeads 
(Invitrogen) and a magnetic particle concentrator (DynamagTM-15, Invitrogen 123.01D). Endothelial 
cells were plated on gelatin-coated 60 mm dishes and cultured during 3 days. After confluence, a 
second purification round was performed and cells plated into a 100 mm-plate. The endothelial 
identity and purity of the cells was confirmed by flow cytometry analysis (Coulter, model EPICS XL) 
of bound anti-ICAM-2 (557444) and anti-PECAM-1 (558738) from BD Pharmigen, and only cultures 
with percentages greater than 95% of endothelial cells were used for experiments. 
 
In vitro vascular permeability assays 
5x104 MLECs were seeded and grown to confluence on collagen-coated transwell inserts 
(Millipore, ECM642). Cells were starved during 6 hours in medium containing 0.5% FBS and, then, 
treated with 100 ng/mL rmTNFα (Immunotools), 5 UI/mL thrombin (Sigma) or 250 ng/mL rmVEGF 
(Immunotools) for 4 hours. Finally, FITC-dextran (1:40) was added on top of the cells and, after 20 
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minutes at room temperature, fluorescence in the lower chamber was determined using a Varioskan 
plate reader (Thermo Scientific). 
Human umbilical vein endothelial cells (HUVECs) cells were grown in EBM-2 medium 
supplementd with EGM-2 SingleQuots (Lonza). 106 cells at passage 3 were transfected using the 
Amaxa nucleofector system with 30 pmol of Podxl-specific or scrambled siRNAs (Ambion) and, 
them, 0.25 x 103 cells were seeded on colagen-coated transwell inserts and grown for a total period of 
48 hours. Cells were treated with 100 ng/mL rhTNFα (R&D) for 16 hours, and with 250 ng/mL 
rhVEGF (Immunotools) or 100 ng/mL LPS (Sigma) for 2 hours. Then, FITC-dextran (1:20) was 
added and, after 1 hour, fluorescence was determined in the low chamber. 
 
In vitro leukocyte transmigration assay 
The murine macrophage cell line PU5-1.8 was cultured on 75 cm2 flasks with DMEM medium 
supplemented with 20% FBS and penicillin/streptomycin. 5x104 MLECs were grown to confluence on 
gelatine-coated 96-transwell plates (Corning, 3388) and starved during 4 hours in serum-free medium 
containing 0.1% BSA. The lower chamber was filled with medium plus 100 ng/mL TNFα, 5 UI/mL 
thrombin, or 250 ng/mL VEGF as chemoattractants and 105 macrophagic cells were added to the 
endothelial culture. Cells were incubated at 37ºC for 2 hours and, then, macrophages in the lower 
chambers of transwells were counted in a flow cytometer (Coulter flow cytometer model EPICS XL). 
 
In vivo pulmonary vascular permeability 
A modification of the Miles assay was used to quantify vascular permeability in five control and 
five KO mice (Moitra et al., 2007). Briefly, mice were injected via the lateral tail vein with 25 mg/kg 
Evan’s blue dye (EBD) 1 hour before sacrifice. After perfusion and sacrifice under isoflurane 
anesthesia on a mask, lung tissue was excised and EBD remaining in 100 mg of air-dried tissue 
parenchyma was extracted in formamide for 24 hours at 55ºC. The optical density of the supernatants 
was read at 620 nm on a spectrophotometer. 
 
Immunofluorescence microscopy of endothelial cells 
5x104 MLECs were grown to confluence on gelatin-coated glass-bottom plate dishes (MatTek 
Corporation). Cells were fixed with 4% paraformaldehyde, blocked and permeabilized with 0.5% 
Triton X-100 in PBS-0.5% BSA, and incubated overnight at 4ºC with goat polyclonal anti-Podxl 
(AF1556, R&D), rabbit polyclonal anti-VE-cadherin (PA5-19612, Thermo Scientific), rabbit 
monoclonal anti-β-catenin (ab32572, abcam), rabbit monoclonal anti-moesin (ab52490, abcam), or 
rabbit polyclonal anti-ERM-P (anti-phospho-ezrin(thr567)/radixin(thr564)/moesin(thr558) (AB3832, 
Millipore). After washing, cells were incubated with secondary antibodies conjugated with Alexa 
Fluor 488 or 546 for 1 hour at room temperature. When indicated, phalloidin-Alexa Fluor 568 was 
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added to the secondary antibody mixture to visualize the actin cytoskeleton. For nuclei labeling, cells 
were incubated with 1 µg/mL Hoechst or DAPI solution for 5 minutes at room temperature. 
Sequential incubation was performed when cells were labeled with primary antibodies raised in the 
same species. Cells were washed with PBS and visualized using the Leica TCS-SP5 confocal 
microscopy system. 
 
Western and flow cytometry analysis 
25 µg of protein lysate of MLECs from “floxed” control or Podxl-deficient mice were analyzed by 
western blot with goat polyclonal anti-Podxl (AF1556, R&D Systems), rabbit polyclonal anti-VE-
cadherin (PA5-19612, Thermo Scientific), rabbit polyclonal anti-claudin-5 (sc-28670, Santa Cruz), 
rabbit polyclonal anti-ERM-P (AB3832, Millipore), and rabbit monoclonal anti-moesin (ab52490, 
abcam). 
20 µg of protein lysate from HUVEC cells nucleofected with Podxl-specific or scrambled siRNAs 
were analyzed with anti-human Podxl (NBP2-25219, Novusbio) and anti-VE-cadherin (PA5-19612, 
Thermo Scientific). 
Surface protein expression was assessed analyzing the binding of rat anti-ICAM-2 (557444) and 
anti-PECAM-1 (558738) from BD Pharmingen, and rat anti-CD34 (14-0341, eBioscience) to 25,000 
MLECs. 
 
Rac 1 and RhoA activation assays 
MLECs were plated on 6 or 12-well plates coated with 5 µg/mL fibronectin. When cells reached 
70-80% confluence, they were starved of serum for 16 hours prior stimulation with 1 U/mL thrombin 
for the indicated periods of time. Cells were rinsed and lysed, and equal amounts of protein (100-150 
µg) were used for determination of GTPase activity of Rac1 and RhoA with the activation assay kits 
from Millipore (Temecula, CA) and Cytoskeleton (Denver, CO), respectively, and following 
manufacturer’s instructions. Precipitated GTP-bound Rac1 and RhoA GTPases were separated by 
SDS-PAGE and detected by immunoblotting with specific mAbs. Total GTPases present in cell 
lysates was determined in a 20 µL of lysate sample, removed prior to pull-down. The relative amount 
of active GTPases was determined by densitometry using Image J free software (NIH). 
 
Statistical analysis  
Kaplan-Meier analysis and log rank test were performed to compare survival of mice groups, using 
the lifetest procedure of SAS version 9.4 (SAS Institute, Cary NC). For other measurements, data for 
the two groups of animals were analyzed using Student’s t-test. The values are expressed as mean ± 
SD. Differences were considered statistically significant if p<0.05. 
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Results 
Deletion of Podxl in mouse endothelial cells (ECs) 
To study the function of podocalyxin (Podxl) in ECs we bred mice harboring podxl alleles carrying 
exons 5-7 flanked by loxP sites (podxlf/f) (Nowakowski et al., 2010) with mice expressing Cre 
recombinase under the control of the tunica intima endothelial kinase 2 (Tie2) promoter (Kisanuki et 
al., 2001) to generate podxlf/fTie-Cre mice. 
We performed RT-PCR to evaluate the expression of Podxl in mouse lung ECs (MLECs) from 
“floxed” (control) and Cre+ (KO) mice. Since both Podxl and Tie2 are also expressed in the 
megakaryocytic lineage (Horvat et al., 1986; Saulle et al., 2012; Schlaeger et al., 2005), we also 
analyzed the expression of Podxl in platelets. As expected, in both cell types, amplification with 
oligonucleotides located in exons 4 and 8 rendered a product corresponding to the normal transcript in 
control mice and a product corresponding to the transcript with deletion of exons 5-7 in KO mice (Fig. 
1A). Amplification using a sense-primer located in exon 7 rendered products corresponding to the 
normal transcript in both mouse lines (not shown), indicating incomplete effectiveness of Cre-
mediated excision in the target lineages. By real-time RT-PCR we estimated that approximately 10% 
of MLECs expressed the Podxl normal transcript in KO mice (Fig. 1B). 
Podxl expression at the protein level was assessed by immunofluorescence staining of histological 
sections of kidney and MLECs in culture. Confocal analysis revealed the presence of Podxl in 
glomeruli but not in the endothelium of blood vessels from KO mice (Fig. 1C). As described by other 
authors (Horvat et al., 1986; Strilic eta al., 2009), in mature vessel Podxl is distributed throughout the 
endothelial cell and, preferentially, localizes to the apical plasma membrane (Supplementary Data 
(SD) Fig. S1). Consistent with the levels of mRNA expression, the number of MLECs that express 
Podxl is markedly reduced in KO mice (Fig. 1C). 
 
Phenotypic analysis of Podxl-deficient mice 
Necropsy and histology.- Podxl-deficient mice are grossly indistinguishable from their littermate at 
birth. Both control and KO mice develop normally and have normal body weight. Although no 
obvious phenotypic abnormalities are observed in KO mice, most die spontaneously between 3 and 4 
months of age (Fig. 2A). Necropsy analysis, performed in a period of 2-4 hours after death and 
without evident signs of autolysis, revealed widespread vascular and organ congestion (organs were 
swollen and showed hyperemic and edematous appearance)  (Fig. 2B). Histological evaluation of 
individual tissues showed the presence of a non-specific arteritis/vasculitis involving vessels of 
different calibers in single or multiple organs (Fig. 3). Inflammatory infiltrates penetrate all layers of 
the arterial wall and can be quite variable in terms of severity and cell type. They were composed 
generally of mixed populations of mononuclear cells with few eosinophils, but predominance of 
polymorphs or a mixed population with abundance of eosinophils was also found in some locations. 
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Endothelial disruption and the presence of edema in the subendothelial space together with 
inflammatory cells were noted in some histological sections. In the heart, inflammatory infiltrates 
were associated with degeneration and necrosis of myocardial fibers and overgrowth of interstitial 
fibrous tissue. These degenerative features were often seen in the atrioventricular septum, at the base 
of papillary muscles, in the valves and, mainly, involving the root of blood vessels. Small necrotic foci 
(micronecrosis), characterized by eosinophilic areas devoid of the typical morphology and with few 
inflammatory cells, were frequently found in liver sections. The lung parenchyma shows 
inflammatory infiltrates in one or more layers of the vessel wall, perivascular lymphoid infiltrates, as 
well as edema and accumulation of inflammatory cells in the alveolar spaces (bronchopneumonia). 
Thickening of the interalveolar septa due to cellular infiltration was observed in some animals. Kidney 
sections revealed mild proliferative glomerulitis and, in some cases, the presence of amorphous, 
eosinophilic material in the urinary space. These lesions were also found in Podxl-deficient mice 
sacrificed at 3-4 months of age. The total number of mice analyzed was eleven (six males and five 
females) and the most common findings were arteritis/panarteritis (100%), myocarditis and 
myocardial degeneration (80%), bronchopneumonia nonsuppurative (80%), mild glomerulonephritis 
(60%), and hepatic micronecrosis (50%). No histological lesions were evident in any of the tissues 
examined in five newborn (Fig. 3) and five 1.5 month-old KO mice (not shown).  
Biochemical analysis.- Plasma concentration of C-reactive protein (CRP) was significantly increased 
in KO mice (0.24+/-0.09 U/L and 45.21+/-18.91 U/L in control and KO mice, respectively). No 
significant differences between the two groups of mice were found in other biochemical markers of 
renal and cardiac dysfunction (SD Table S1). The volume of urine excreted in two matched groups of 
6 control and 6 KO mice was not significantly different. 
MRI analysis of aortic lumen area.- It has been reported that the diameter of the aortic lumen in 
Podxl-deficient embryos was less than half that of the control diameter (Strilic et al., 2009). In our 
study, the lumen of the abdominal aorta was analyzed by MRI in 3 control and 3 KO mice of 3-
months of age. Fourteen axial slices between the diaphragm muscle and the common iliac arteries 
were acquired and the area corresponding to the vascular lumen in each section was analyzed using 
the ImageJ software. No significant differences were observed between control and KO mice in the 
average of the luminal area along the analyzed aortic region (SD Table S2). 
Arterial pressure.- Given the possibility that the absence of Podxl produced endothelial dysfunction 
which impacts on vascular tone, we measured systolic (sBP) and diastolic (dBP) blood pressure in 
control (n=12, 6 males and 6 females) and KO (n=11, 5 males and 6 females) mice using the non-
invasive tail-cuff procedure. sBP was found significantly elevated in two KO mice, one male and one 
female (141 and 144 mmHg, respectively, compared with 123+3.3 mmHg in the control mice). 
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Platelet function.- Consistent with the reduction in the expression of platelet Podxl and similarly to 
Podxlf/f PF4-Cre mice (Pericacho et al., 2011), Tie-Cre+ mice exhibited decreased systemic 
thrombosis in response to i.v. administration of platelet agonists (SD Fig. S2).  
Lung function.- Pulmonary function testing was not performed, but symptoms of clear respiratory 
distress, consisting in arrhythmic and shallow rapid breathing, were observed in some mice shortly 
before dying. Necropsy analysis of these mice showed severe histological lesions in interalveolar 
septa and pulmonary vessels.  
 
Increased sensitivity to LPS of Podxl-deficient mice 
To evaluate the effects of Podxl deficiency on survival after LPS-induced endothelial barrier 
dysfunction, groups of mice received a single intraperitoneal injection of 10, 20, or 40 mg/Kg of LPS, 
and mortality was monitored over a 4-day period (Fig. 4). A markedly significant decrease of survival 
was observed in 9-10 week-old KO mice treated with 20 or 40 mg/Kg of LPS. Mortality of 5-6-week 
old KO mice was also higher than that of control group, but a significant difference was found only 
among those receiving 20 mg/Kg LPS. A cumulative endothelial lesion in older KO mice could 
explain this difference. 
 
Deficiency of Podxl in ECs impairs their function ex vivo 
The histological findings suggested a severe dysfunction of the vascular endothelial barrier in KO 
mice. To study the role of Podxl in controlling the integrity of the endothelial barrier we first 
developed an improved and reproducible method for isolation and culture of MLECs. This method 
yielded cell monolayers with more than 95% positive cells as assessed by flow cytometry 
measurement of ICAM-2 expression. Flow cytometry analysis revealed that Podxl-deficient MLECs 
from 3-month-old mice show surface expression levels of PECAM-1 and CD34 similar to control 
cells. However, a significant 10-20% increase in ICAM-2 surface labeling was observed in MLECs 
from KO mice (SD Fig. S3). 
To investigate whether the absence of Podxl could alter in vitro endothelial monolayer 
permeability, we first used a FITC-dextran transwell assay. As shown in Fig. 5A, a significant 
increase of dextran movement was obtained in Podxl-deficient cells. This effect was observed in basal 
conditions as well as in cells stimulated with barrier-disruptive agonists such as VEGF, TNF-α, and 
thrombin. We next performed leukocyte transmigration assays and verified that the number of 
macrophagic PU5-1.8 cells that transmigrated through Podxl-deficient MLECs was significantly 
higher in both basal and stimulated experimental conditions (Fig. 5A). These data suggest that 
regulation of permeability and leukocyte transmigration through mouse microvascular ECs require 
Podxl. In accordance with these data, Evan’s blue dye vascular leakage assays showed that lungs from 
KO mice exibited a significant increase in permeability (Fig. 5B). 
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To further confirm the effect of the absence of Podxl on permeability, Podxl expression was 
downregulated in HUVEC cells by transfection of Podxl-specific siRNAs. As shown in SD Fig. S4, 
Podxl-depleted HUVEC cells were more permeable to FITC-dextran in response to various barrier-
disruptive stimuli.  
 
Disassembly of adherens junctions in Podxl-deficient MLECs 
Western analysis showed no differences in either VE-cadherin or claudin-5 in Podxl-deficient 
MLECs (SD Fig. S3). To investigate the consequence of Podxl deficiency in cadherin-mediated cell-
to-cell contacts, we analyzed VE-cadherin staining in confluent monolayer cultures of MLECs treated 
with thrombin, which is known to induce a rapid and reversible disruption of endothelial intercellular 
junctions. Disruption of VE-cadherin staining was observed in both kinds of cells after thrombin 
stimulation; however, a continuous staining indicating restoration of the endothelial barrier was 
appreciated after 1-hour of treatment in control cells but not in Podxl-deficient cells (Fig. 5C). Besides 
inducing paracellular gaps, thrombin is known to rapidly stimulate F-actin fiber stress formation. As 
shown in Fig. 5D, F-actin stress fibers remained in Podxl-deficient cells but not in control cells 1-hour 
after thrombin stimulation. 
The ERM (ezrin-moesin-radixin) family of actin-binding linkers participates in EC barrier 
modulation, being moesin is the most expressed ERM protein in a number of ECs (Adyshev et al., 
2013). Total content of moesin were similar in control and Podxl-deficient cells (SD Fig. S3) but, as 
previously reported (Strilic et al., 2009), Podxl-deficient ECs showed a diffuse pattern of moesin 
distribution, in contrast to its accumulation at the cell-cell contacts in cells from control mice (Fig. 
5E). 
MLECs from both control and KO mice exhibited the highest levels of phosphorylated-ERM 
(ERM-P) immediately after detachment (SD Fig. S3). In fully spread cells, phosphorylation of ERM 
was transiently induced by thrombin. In contrast to control cells, ERM-P remained high after 45 
minutes in Podxl-deficient cells (Fig. 6). 
 
Podxl deletion alters the pattern of RhoA activation induced by thrombin 
Junctional permeability is regulated by small GTPases (Spindler et al., 2010). LPS, thrombin, and 
VEGF increase activation of RhoA and endothelial permeability, and activation of Rac-1 and Cdc42 
has been shown to stabilize the microvascular endothelial barrier. A significant difference was 
observed in the pattern of RhoA activation induced by thrombin between control and Podxl-depleted 
MLECs. As described in human ECs (Beckers et al., 2010), thrombin induced a rapid and transient 
activation of RhoA in MLECs. However, a longer sustained activation of RhoA was observed in 
Podxl-deficient cells (Fig. 6). In contrast to RhoA, no significant differential effects of thrombin were 
detected in Rac1 GTPase activation (Fig. 6).   
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Discussion 
To study the functional significance of Podxl expression in endothelial cells (ECs), we bred mice 
bearing loxP-flanked alleles encoding Podxl (podxl f/f) (Nowakowski et al., 2010) with mice 
expressing Cre recombinase under the control of the Tie2 promoter (Kisanuki et al., 2001) to generate 
podxlf/fTie2-Cre mice. Efficiency of Cre-mediated ablation of Podxl in lung ECs (MLECs), assessed 
by real time RT-PCR analysis of Podxl transcripts, showed 90% deletion of the podxl allele. 
Consistent with this, similar proportion of cells lacking Podxl was found by immunofluorescence 
analysis of MLECs in culture. Immunohistochemical staining of kidney sections revealed the presence 
of Podxl in glomeruli but not in the endothelium of blood vessels from Cre+ mice, indicating the 
specificity of the Cre-mediated ablation of podxl gene. 
Podxl-deficient mice (KO mice) apparently grow normally but most die spontaneously at 3-4 
months of age. According to histological analysis, they develop a nonspecific vasculitis that 
essentially consists in an inflammatory infiltrate within the vessel wall frequently associated with 
degenerative changes. These features were found in vessels of different caliber in all analyzed tissues, 
suggesting that efficient deletion of podxl in the vascular bed was generalized. The severity of 
myocardial and pulmonary infiltration could be the direct cause of death. The absence of pathologic 
findings in histological sections of euthanized newborn and 1.5-month old mice suggests that a 
gradually accumulated damage induced by the lack of Podxl precedes the onset of symptoms. 
Supporting this, compared with that of their age-paired controls, the sensitivity of 3-month old mice to 
LPS-induced endothelial barrier damage was higher than that of younger animals. 
Since Podxl and Tie2 are both expressed in platelets, it cannot be ruled out that ablation of Podxl in 
platelets could eventually contribute to some of the pathological features. However, in our previously 
reported mouse model (podxlfl/flPf4-Cre mice), in which Podxl deletion was restricted to platelets 
(Pericacho et al., 2011), no vascular-related lesions were found in deficient mice. Thus, the phenotype 
of podxlfl/flTie2-Cre mice is basically due to the absence of Podxl in ECs. A marked increase in plasma 
levels of C-reactive protein (CRP) was detected in all analyzed KO mice. In humans, CRP is a known 
marker of inflammation and cardiovascular disease (Halim et al., 2014), and it is being also 
considered an active participant in the cardiovascular pathogenesis by promoting endothelial 
dysfunction (Bisoendial et al., 2010; Hein et al., 2009). In mice, CRP is not considered an acute-phase 
reactant but it can modulate the inflammatory response (Kapur et al., 2015). Therefore, it cannot be 
discarded the possibility that sustained high levels of CRP may exacerbate the disease in Podxl-
deficient mice. No biochemical evidence of renal failure was detected in mice showing mild 
histological lessions in the kidneys. Other phenotypic abnormalities, such as increased blood pressure 
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and evident respiratory distress, were observed only in some animals. We can not rule out that 
hypertension detected in 2 of 11 KO animals was a casual finding. However, histological lesions 
found in mice with respiratory distress suggest that both findings are related and are due to the 
absence of Podxl. Podxl has been shown to be required for early vascular lumen formation (Strilic et 
al., 2009), but we could not detect a significant reduction in the lumen of abdominal aorta in KO mice.  
In the total knockout model (Doyonnas et al., 2001), approximately 25% of the podxl-/- embryos 
obtained by Caesareas section exhibited mild to severe edema. Recently, in a mouse model with 
conditional ablation of podxl driven by the VE-cadherin promoter (Debruin et al., 2014), Podxl was 
shown to regulate murine lung vascular permeability by altering EC adhesion. In the present study, the 
severe histologic lesions of mice with more extensive deletion of Podxl in the vascular bed, besides 
reinforcing this notion, reveal an essential role of Podxl in the regulation of the endothelial barrier. 
Levels of CD34 were similar in control and Podxl-deficient ECs; thus, the loss of Podxl expression by 
the vasculature does not result in a compensatory increase in the expression of other related 
sialomucins, as previously suggested (Doyonnas et al., 2001).  
To further explore the mechanism by which the lack of Podxl leads to vascular damage, we first 
developed an optimized procedure for obtaining of highly enriched EC cultures from pulmonary 
microvasculature of 3-month-old mice. Although expression of endothelial surface markers is 
conserved, Podxl-deficient cell monolayers exhibited a significant increase in basal permeability to 
dextran and inflammatory cells. Permeability was also higher in cells stimulated with endothelial 
barrier-disruptive agents such as thrombin. Migration through the junctions between adjacent ECs is 
the major pathway for leukocyte extravasation in several tissues (Shulted et al., 2011). Stability of cell 
contacts is mainly maintained by VE-cadherin, the main component of endothelial adherens junctions 
in vivo as well as in vitro (Shulted et al., 2011). Consistent with this, the immunofluorescence analysis 
of cell-cell contacts showed that after 1-hour treatment with thrombin, F-actin stress fibers and gaps in 
the VE-cadherin labelling remained only in Podxl-deficient cells, indicating that recovery of the 
barrier disruption induced by thrombin is delayed in the absence of Podxl. In agreement with these 
results, increased pulmonary vascular permeability was detected in vivo in KO mice. 
Podxl is known to interact with the ezrin-moesin-radixin (ERM) complex, a family of actin-
binding linkers that participate in EC barrier modulation (Adyshev et al., 2013). The abnormal 
distribution of moesin observed in Podxl-deficient MLECs was also reported in embryos of the Podxl 
total knockout mouse model associated to defective lumen formation during aorta development 
(Strilic et al., 2009). However, in the present study, in vivo determination of aortic cross-sectional area 
by MRI analysis did not reveal apparent difference between control and KO mice. It is possible that 
residual expression of Podxl due to incomplete Cre excision was sufficient to support normal lumen 
formation.  
Consistent with the delayed restoration of VE-cadherin labeling and actin-based cytoskeleton, the 
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recovery of basal levels of phosphorylated ERM after thrombin stimulation was significantly slower in 
Podxl-deficient cells. The ERM proteins have been shown to act both upstream and downstream of the 
small Rho GTPases (Fehon et al., 2010). In human pulmonary artery endothelial cells (HPAEC), ERM 
proteins are critically involved in the thrombin-induced disruption of the endothelial barrier, and it has 
been shown that ERM phosphorylation can induce actin cytoskeleton changes and endothelial hiper-
permeability via RhoA activation (Adyshev et al., 2013). In agreement with this, our study shows that 
persistent phosphorylation of ERM and delayed recovery of endothelial integrity in Podxl-deficient 
MLECs after thrombin stimulation was accompanied by sustained activation of RhoA. Although we 
do not provide a molecular mechanism for the role of Podxl in vascular permeability, the results 
clearly suggest that the lack of Podxl alters the intracellular signaling machinery responsible for 
restoring the endothelial barrier integrity after injury. Moesin is the most abundant component of the 
ERM complex in endothelial cells (Adyshev et al., 2013). It is possible that the altered distribution of 
moesin in KO cells ameliorates their recruitment and activation at the plasma membrane. This 
interpretation of the results would explain that appearance of pathological symptoms requires either 
prolonged exposure of the Podxl-deficient endothelium or a severe inflammatory stress like LPS 
administration. 
In addition, mechanisms related with the adhesive and sialylation-dependent functions of Podxl 
could also be involved in the failure of the Podxl-deficient vascular endothelium. The role of Podxl in 
cell adhesion is controversial as both pro- and anti-adhesive functions have been described depending 
on cell type and glycosylation feature (Larrucea et al., 2007; Larrucea et al., 2008; Takeda et al., 
2000), leading also to suggest that the amount of Podxl may regulate adhesion by altering the 
distribution and effects of other adhesion molecules on the cell surface (Nielsen and McNagny, 2009). 
Thus, it cannot be ruled out that the lack of Podxl resulted in exposure of normally hidden adhesion 
molecules, thereby increasing the quantity of leukocytes entering organs in both basal immune 
surveillance and inflammation. In agreement, increased exposure of surface ICAM-2 was consistently 
observed in Podxl-deficient MLEC cultures. 
To our knowledge, this podxlf/fTie2-Cre mouse is the first genetically modified model resembling 
features of human vasculitis, a heterogeneous group of rare diseases with a common characteristic: 
inflammation of blood vessels walls. The pathogenesis of the disease is poorly understood and, in 
most of cases, treatment is symptomatic and directed to limit organ damage (Sharma et al., 2011). 
These mice might serve as a valuable tool for the study of vasculitis and the identification of 
molecules or mechanisms that may be relevant targets for controling vascular permeability changes 
associated with a number of diseases. Also, since mutations of podxl have been associated with human 
diseases (Barua et al., 2014; Casey et al., 2006), we raise the possibility that certain mutations may 
disrupt its endothelial barrier protective function and, consequently, be associated with some 
cardiovascular events. 
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In summary, the generation of mice with conditional ablation of the podxl gene restricted to 
vascular endothelium has revealed an essential role of Podxl in the control of vascular permeability. 
This control seems to be exerted by regulating the mechanism(s) involved in the restoration of barrier 
integrity after injury. Besides its utility for studying the function of Podxl in the vascular endothelium, 
this mouse model is a useful tool for the study of vascular inflammatory processes and identification 
of new drug targets.  
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Figures and legends 
Figure 1 
 
 
 
Figure 1. Podxl expression in “floxed” (control) and Cre+ (KO) mice. Total RNA was extracted 
from mouse lung ECs (MLECs) and platelets from three control and three KO mice, and the RNA 
mixture was used for RT-PCR amplification of Podxl and β-actin transcripts, as described in Methods. 
(A) Amplification with oligonucleotides located in exons 4 and 8 results in products of normal size in 
control mice and products with deletion of exons 5-7 in KO mice. (B) Relative expression of Podxl 
normal transcript in MLECs from control and KO mice was determined by real-time PCR using 
oligonucleotides located in exon 7 and 8. The results were quantified and normalized to β-actin 
expression and are the average of two independent experiments performed in triplicate with different 
RNA mixtures of three mice of each type. (C) Immunofluorescence detection of Podxl in kidney 
sections (a, b) and cultured MLECs (c, d) from control and KO mice. Nuclei were stained with DAPI 
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(blue). The assay was performed three times with similar results. In panel C, scale bars: 50 µm (a and 
b), 20 µm (c and d). 
Figure 2 
 
 
 
Figure 2. Survival and pathological findings in Podxl-deficient mice. (A) Kaplan-Meier survival 
curves of control and KO sibling mice of at least 10 litters from 5 different breeding pairs. In a sample 
of 51 KO mice, 25 mice (49%) died before 3 months, 21 (41%) between 3 and 4 months, 3 (6%) after 
4 months, and only 2 mice (4%) were alive at 6 months of age. None of the 40 control mice died 
spontaneously within the first 6 months of life. As shown in the figure, 6 of these animals were 
euthanized after 4.5 months. (B) (a-b) Marked congestion of the inferior vena cava (IVC) and the left 
renal vein (LRV) in a KO mouse. (c-d) Pulmonary congestion in a KO mouse. Representative images 
obtained in necropsy analysis of more than ten mice. Scale bars: 0.5 cm. 
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Figure 3 
 
 
 
Figure 3. Histological lesions in Podxl-deficient mice. Representative images of hematoxylin and 
eosin (H&E)-stained tissue sections from control and KO mice. Alterations described below were 
found in tissues of eleven 3-month old KO mice but not in five KO newborns and five 3-month old 
control mice. (A) Subendothelial edema (arrow) and inflammatory cells infiltrating both the medial 
and adventitial layers in a pulmonary arteriole. (B) Inflammatory infiltrate surrounding necrotic areas 
(asterisks) devoid of nuclei in liver sections. (C) Alveolar edema and abundance of inflammatory cells 
in alveoli and surrounding pulmonary vessels, characteristics of non suppurative bronchopneumonia. 
(D) Heart section showing a severe myocardial infiltration of inflammatory cells (arrow) 
asymmetrically distributed around a large vessel (arrow). (E) Vascular congestion (arrow) and 
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significant increase of cellularity in renal glomeruli. Images were taken at 40x (A, B and E), 20x (C) 
or 10x magnification (D). Scale bars: 50 µm (A and B), 100 µm (C and E), and 400 µm (D). 
Figure 4 
 
 
 
Figure 4. Survival of LPS-treated mice. Control and KO mice aged 9-10 weeks (A) or 5-6 weeks 
(B) were treated with intraperitoneal administration of LPS, and survival was monitored over 4 days. n 
indicates the number of animals analyzed in each group. (C) Kaplan-Meier analysis and log rank test 
were performed to compare survival of mice groups, using the lifetest procedure of SAS version 9.4 
(SAS Institute, Cary NC). P-values in bold indicate that the survival curves of the indicated group are 
significantly different. 
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Figure 5 
 
 
 
Figure 5. Altered permeability and adherens junctions in Podxl-deficient ECs. (A) Confluent 
monolayers of MLECs from two control and two KO mice grown in transwells coated with collagen 
were starved and estimulated for 4 hours with 250 ng/mL VEGF, 100 ng/mL TNFα, or 5 UI/mL 
thrombin, and permeability to FITC-dextran was measured as described under Methods. In 
macrophage transmigration assays, MLECs were grown to confluence on gelatin-coated transwells 
and, then, PU5-1.8 macrophage cells were seeded on top of the transwell and VEGF (250 ng/mL), 
TNFα (100 ng/mL), or thrombin (5 UI/mL) was added to medium in the lower chamber. 
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Transmigrated cells were counted as described under Methods. The Anderson-Darling test was used to 
verify normal distribution of data. Data are expressed as percentage of the value obtained in non-
stimulated cells from control mice and represent the mean±SD of four independent experiments. By 
two tailed, unpaired, t-test: * P<0.05; ** P<0.005. (B) Pulmonary vascular permeability was assessed 
in five 3-month old control or KO mice as described in Methods. By two tailed, unpaired, t-test: * 
P<0.02. (C-D-E) Immunofluorescence analysis of Podxl-deficient MLECs. Confluent MLEC cultures 
from three control and three KO mice were fixed, permeabilized, stained and analyzed in a confocal 
microscope as described in Methods. (C) Cells were stimulated with 1 IU/mL thrombin for 1 hour 
before staining with anti-Podxl (green) and anti-VE-cadherin (red). Nuclei were stained with Hoechst 
(blue). (D) Cells were stimulated with 1 IU/mL thrombin for 1 hour before staining with anti-VE-
cadherin (cyan) and phalloidin (red) for F-actin filaments. Nuclei were stained with Hoechst (blue). 
Scale bars, 10 µm. (E) Confocal xz sections showing enrichment of moesin at the cell-cell contacts in 
control (arrows) but not in Podxl-deficient cells. Nuclei were stained with DAPI (blue). 
Representative images of four independent assays. 
 
 
 
 
Figure 6 
 
 
 
Figure 6. Effect of Podxl-depletion on thrombin-induced ERM phosphorylation and activation 
of RhoA and Rac1 GTPases. Confluent MLEC cultures from control and KO mice were serum-
starved for 2 hours and, then, stimulated with 1 UI/ml thrombin for the indicated times. Western blot 
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detection of phosphorylated ERM (ERM-P) and active RhoA (RhoA-GTP) and Rac1 (Rac1-GTP) 
were assessed as described in Methods. Representative experiments are shown and bar graphs 
represent the mean±SD of four independent experiments. By t-test * p<0.05. 
 
 
 
 
